Quench Bio scores $50 mln Series A

Cambridge, Massachusetts-based Quench Bio, a biotechnology company focused on severe inflammatory diseases, has raised $50 million in Series A funding.

Cambridge, Massachusetts-based Quench Bio, a biotechnology company focused on severe inflammatory diseases, has raised $50 million in Series A funding. Quench Bio’s backers include Atlas Venture, Arix Bioscience, RA Capital and AbbVie Ventures.

Source: Press Release